{"id":"https://openalex.org/W4402736741","doi":"https://doi.org/10.1111/bcp.16255","title":"Concentration\u2010QTc analysis of soticlestat in healthy adults: An alternative to a thorough QT study","display_name":"Concentration\u2010QTc analysis of soticlestat in healthy adults: An alternative to a thorough QT study","publication_year":2024,"publication_date":"2024-09-23","ids":{"openalex":"https://openalex.org/W4402736741","doi":"https://doi.org/10.1111/bcp.16255","pmid":"https://pubmed.ncbi.nlm.nih.gov/39313221","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/11773096"},"language":"en","primary_location":{"id":"doi:10.1111/bcp.16255","doi":"https://doi.org/10.1111/bcp.16255","is_oa":true,"landing_page_url":"https://doi.org/10.1111/bcp.16255","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bcp.16255","source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bcp.16255","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5039368137","display_name":"Wei Yin","orcid":"https://orcid.org/0000-0002-4834-5783","observed_orcids":["https://orcid.org/0000-0002-4834-5783"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Wei Yin","raw_affiliation_strings":["Takeda Pharmaceutical Company Ltd  Cambridge Massachusetts USA"],"raw_orcid":"https://orcid.org/0000-0002-4834-5783","affiliations":[{"raw_affiliation_string":"Takeda Pharmaceutical Company Ltd  Cambridge Massachusetts USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006484440","display_name":"Nobuhito Dote","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nobuhito Dote","raw_affiliation_strings":["PRA Development Center K.K.  Osaka Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PRA Development Center K.K.  Osaka Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023716912","display_name":"Hiroyuki Fukase","orcid":"https://orcid.org/0000-0002-9488-0947","observed_orcids":["https://orcid.org/0000-0002-9488-0947"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hiroyuki Fukase","raw_affiliation_strings":["Clinical Research Hospital Tokyo  Tokyo Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Hospital Tokyo  Tokyo Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032824830","display_name":"Manami Imazaki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Manami Imazaki","raw_affiliation_strings":["Takeda Development Center Japan Takeda Pharmaceutical Company Ltd  Osaka Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Takeda Development Center Japan Takeda Pharmaceutical Company Ltd  Osaka Japan","institution_ids":["https://openalex.org/I44892455"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113867766","display_name":"Kohei Shimizu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kohei Shimizu","raw_affiliation_strings":["Takeda Development Center Japan Takeda Pharmaceutical Company Ltd  Osaka Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Takeda Development Center Japan Takeda Pharmaceutical Company Ltd  Osaka Japan","institution_ids":["https://openalex.org/I44892455"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Shinichi Takeda","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shinichi Takeda","raw_affiliation_strings":["Takeda Development Center Japan Takeda Pharmaceutical Company Ltd  Osaka Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Takeda Development Center Japan Takeda Pharmaceutical Company Ltd  Osaka Japan","institution_ids":["https://openalex.org/I44892455"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040398689","display_name":"B\u00f6rje Darp\u00f6","orcid":"https://orcid.org/0000-0002-5008-5052","observed_orcids":["https://orcid.org/0000-0002-5008-5052"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Borje Darpo","raw_affiliation_strings":["Clario  Philadelphia Pennsylvania USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clario  Philadelphia Pennsylvania USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040190878","display_name":"Hongqi Xue","orcid":"https://orcid.org/0009-0004-3157-1874","observed_orcids":["https://orcid.org/0009-0004-3157-1874"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hongqi Xue","raw_affiliation_strings":["Clario  Philadelphia Pennsylvania USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clario  Philadelphia Pennsylvania USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5004004308","display_name":"Mahnaz Asgharnejad","orcid":"https://orcid.org/0000-0001-8060-2148","observed_orcids":["https://orcid.org/0000-0001-8060-2148"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mahnaz Asgharnejad","raw_affiliation_strings":["Takeda Pharmaceutical Company Ltd  Cambridge Massachusetts USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Takeda Pharmaceutical Company Ltd  Cambridge Massachusetts USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5039368137"],"corresponding_institution_ids":[],"apc_list":{"value":4550,"currency":"USD","value_usd":4550},"apc_paid":{"value":4550,"currency":"USD","value_usd":4550},"fwci":0.2811,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":{"value":0.60786459,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"91","issue":"2","first_page":"338","last_page":"352"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10217","display_name":"Cardiac electrophysiology and arrhythmias","score":0.8285999894142151,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10217","display_name":"Cardiac electrophysiology and arrhythmias","score":0.8285999894142151,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.055799998342990875,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.02879999950528145,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/qtc-prolongation","display_name":"QTc prolongation","score":0.8610000014305115},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.6650000214576721},{"id":"https://openalex.org/keywords/cardiac-safety","display_name":"cardiac safety","score":0.7850000262260437},{"id":"https://openalex.org/keywords/n-oxide-metabolite","display_name":"N-oxide metabolite","score":0.8479999899864197},{"id":"https://openalex.org/keywords/liver-dysfunction","display_name":"liver dysfunction","score":0.8669999837875366},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.6439999938011169},{"id":"https://openalex.org/keywords/itraconazole","display_name":"itraconazole","score":0.890999972820282},{"id":"https://openalex.org/keywords/mefenamic-acid","display_name":"mefenamic acid","score":0.9940000176429749},{"id":"https://openalex.org/keywords/fridericia-correction","display_name":"Fridericia correction","score":0.6570000052452087},{"id":"https://openalex.org/keywords/safety-margin","display_name":"safety margin","score":0.4860000014305115},{"id":"https://openalex.org/keywords/drug-repurposing","display_name":"drug repurposing","score":0.4429999887943268}],"concepts":[{"id":"https://openalex.org/C118441451","wikidata":"https://www.wikidata.org/wiki/Q12074763","display_name":"QT interval","level":2,"score":0.7823013067245483},{"id":"https://openalex.org/C2779703243","wikidata":"https://www.wikidata.org/wiki/Q653924","display_name":"Long QT syndrome","level":3,"score":0.5912939310073853},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5856911540031433},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.34791305661201477}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004562","descriptor_name":"Electrocardiography","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006339","descriptor_name":"Heart Rate","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008133","descriptor_name":"Long QT Syndrome","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015716","descriptor_name":"Electrocardiography, Ambulatory","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D064368","descriptor_name":"Healthy Volunteers","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1111/bcp.16255","doi":"https://doi.org/10.1111/bcp.16255","is_oa":true,"landing_page_url":"https://doi.org/10.1111/bcp.16255","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bcp.16255","source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:11773096","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11773096","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11773096/pdf/BCP-91-338.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Clin Pharmacol","raw_type":"Text"},{"id":"pmid:39313221","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/39313221","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of clinical pharmacology","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1111/bcp.16255","doi":"https://doi.org/10.1111/bcp.16255","is_oa":true,"landing_page_url":"https://doi.org/10.1111/bcp.16255","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bcp.16255","source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320310030","display_name":"Takeda Pharmaceuticals U.S.A.","ror":"https://ror.org/03bygaq51"},{"id":"https://openalex.org/F4320333804","display_name":"Takeda Canada","ror":"https://ror.org/056d2rn68"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4402736741.pdf","grobid_xml":"https://content.openalex.org/works/W4402736741.grobid-xml"},"referenced_works_count":18,"referenced_works":["https://openalex.org/W2081722421","https://openalex.org/W2771291368","https://openalex.org/W3092308854","https://openalex.org/W3112197865","https://openalex.org/W3120185266","https://openalex.org/W3138320059","https://openalex.org/W3144240552","https://openalex.org/W3159699587","https://openalex.org/W4205931560","https://openalex.org/W4285587978","https://openalex.org/W4292004352","https://openalex.org/W4362520887","https://openalex.org/W4387157852","https://openalex.org/W4389991086","https://openalex.org/W4390025027","https://openalex.org/W4390030366","https://openalex.org/W4392516947","https://openalex.org/W4400593614"],"related_works":["https://openalex.org/W4205931560","https://openalex.org/W1784090510","https://openalex.org/W2070883942","https://openalex.org/W2161887324","https://openalex.org/W1983711723","https://openalex.org/W2332714857","https://openalex.org/W1602987494","https://openalex.org/W4401406420","https://openalex.org/W4200559410","https://openalex.org/W2006614061"],"abstract_inverted_index":{"AIM:":[0],"This":[1],"study":[2,33],"aimed":[3],"to":[4],"examine":[5],"the":[6],"cardiac":[7],"and":[8,11,53,120,169,202],"overall":[9],"safety":[10,93,188],"pharmacokinetic":[12],"(PK)":[13],"profiles":[14],"of":[15,34,100,110,194,231,242],"soticlestat":[16,35,48,112,126,168,223,252],"(TAK-935),":[17],"an":[18],"oral,":[19],"first-in-class":[20],"selective":[21],"cholesterol":[22],"24-hydroxylase":[23],"inhibitor.":[24],"METHODS:":[25],"Data":[26],"came":[27],"from":[28,77],"a":[29,87,137,243],"randomised,":[30],"phase":[31],"1":[32,46,106],"in":[36,44,55,130,228,237],"33":[37],"healthy":[38],"Japanese":[39],"adults":[40,43],"(NCT04461483);":[41],"24":[42],"Part":[45,56,205],"(single-dose":[47],"200-1200":[49],"mg":[50,60,114,128,185],"or":[51,63,117,227],"placebo)":[52],"9":[54],"2":[57,122],"(soticlestat":[58,183],"100-300":[59],"twice":[61,186],"daily":[62],"placebo":[64],"for":[65,97,141,157,167,174,192,219],"21":[66],"days).":[67],"PK":[68],"sample":[69],"collection":[70],"was":[71,84,216],"paired":[72],"with":[73,115,132,222,250],"12-lead":[74],"electrocardiogram":[75],"data":[76],"continuous":[78],"Holter":[79],"recordings.":[80],"The":[81],"concentration-QTc":[82,147],"relationship":[83],"analysed":[85],"using":[86],"linear":[88],"mixed-effects":[89],"model.":[90],"QTc":[91],"prolongation":[92,221],"margins":[94,189],"were":[95,162,190],"determined":[96],"two":[98,229],"scenarios":[99,193,230],"calculated":[101,195],"high":[102,196,232],"clinical":[103,197,233,253],"exposures:":[104],"scenario":[105,121],"(NCT05064449)":[107],"involved":[108,124],"coadministration":[109],"single-dose":[111,125],"300":[113,127,184],"itraconazole":[116],"mefenamic":[118],"acid":[119],"(NCT05098054)":[123],"administration":[129],"participants":[131,207],"mild/moderate":[133],"hepatic":[134],"impairment":[135],"(implementing":[136],"3-fold":[138],"dose":[139],"reduction":[140],"moderate":[142],"severity).":[143],"RESULTS:":[144],"Based":[145],"on":[146],"analysis,":[148],"placebo-corrected":[149],"change-from-baseline":[150],"QT":[151,220,245],"values":[152],"(90%":[153],"confidence":[154],"intervals),":[155],"corrected":[156],"heart":[158],"rate":[159],"(Fridericia's":[160],"method),":[161],"0.94":[163],"ms":[164,171],"(-2.35,":[165],"4.23)":[166],"0.63":[170],"(-3.15,":[172],"4.41)":[173],"its":[175],"N-oxide":[176],"metabolite":[177],"plasma":[178],"concentrations":[179],"at":[180,224],"therapeutic":[181,225],"doses":[182,226],"daily);":[187],">2-fold":[191],"exposures.":[198],"No":[199],"(Part":[200],"1)":[201],"five":[203],"(83.3%;":[204],"2)":[206],"experienced":[208],"treatment-emergent":[209],"adverse":[210],"events":[211],"(all":[212],"mild).":[213],"CONCLUSION:":[214],"There":[215],"no":[217],"evidence":[218],"exposures,":[234],"which":[235],"resulted":[236],"regulatory":[238],"agencies":[239],"waiving":[240],"requirements":[241],"thorough":[244],"study.":[246],"Safety/PK":[247],"findings":[248],"aligned":[249],"previous":[251],"studies.":[254]},"counts_by_year":[{"year":2024,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2024-09-24T00:00:00"}